NCT03926806 is a NA clinical trial of Plain yoghurt in Type 2 Diabetes Mellitus, sponsored by Harokopio University.

Who is sponsoring NCT03926806?

NCT03926806 is sponsored by Harokopio University.

What drugs are being tested in NCT03926806?

Interventions in NCT03926806: Plain yoghurt, Vitamin B yoghurt.

What condition does NCT03926806 study?

NCT03926806 studies Type 2 Diabetes Mellitus.

Is NCT03926806 still recruiting?

NCT03926806 is currently completed. Last updated 26 April 2019.

Last reviewed 2019-04-26 · How we verify

NCT03926806

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yoghurt Consumption, Body Weight Management and Glycemic Control of T2DM Patients

Completed NA Last updated 26 April 2019

What this trial tests

NA trial testing Plain yoghurt in Type 2 Diabetes Mellitus in 33 participants. Completed in 29 December 2018.

Timeline

25 November 2016

Primary endpoint
8 August 2018

29 December 2018

Quick facts

Lead sponsor	Harokopio University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	33
Start date	25 November 2016
Primary completion	8 August 2018
Estimated completion	29 December 2018

Drugs / interventions tested

Plain yoghurt
Vitamin B yoghurt

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →

Sponsor

Harokopio University

Who can join

Adults 45 to 75, any sex, with Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study investigates the effects of consumption of yoghurt enriched with vitamins B compared to plain yoghurt, on body weight management and glycemic control of overweight/obese T2DM patients. It also investigates the effect of plain yoghurt consumption on gut hormones response of T2DM patients.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Pertinence of nutriments for a stalwart body.
Kaur R, Sood A, Kanotra M, Arora S, et al · · 2021 · cited 4× · PMID 34435290 · DOI 10.1007/s11356-021-16060-1
Effects of 12-week, non-energy-restricted dietary intervention with conventional yogurt οn appetite hormone responses of type 2 diabetic patients.
Yanni AE, Konstantopoulos P, Kartsioti K, Binou P, et al · · 2021 · cited 3× · PMID 34925790 · DOI 10.1002/fsn3.2606

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Harokopio University trials

Trials by the same sponsor.

NCT06997510 — Better4All Personalized Intervention · NA · not yet recruiting
NCT07233707 — Load and Hold: Impact of 7-Day Creatine Monohydrate Loading on Breath-Hold Cycling Performance · NA · enrolling by invitation
NCT07505680 — Time-restricted Feeding and Health · NA · completed
NCT07120802 — Better4All Personalized Intervention Pilot Study · NA · recruiting
NCT07190066 — MELIORA Data Collection Campaigns · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03926806 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Harokopio University
Last refreshed: 26 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03926806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing